Copyright
©The Author(s) 2016.
World J Hepatol. Aug 18, 2016; 8(23): 976-984
Published online Aug 18, 2016. doi: 10.4254/wjh.v8.i23.976
Published online Aug 18, 2016. doi: 10.4254/wjh.v8.i23.976
Table 2 Number/sizes of focal lesions according to Milan criteria
Patients | No. of focal lesions | Size of focal lesions (cm) |
Patient 1 | 3 focal lesions | 1.5, 1 and 1 |
Patient 2 | Unifocal | 2.5 |
Patient 3 | 3 focal lesions | 2, 2.5 and 3 |
Patient 4 | 3 focal lesions | 2, 2 and 3.5 |
Patient 5 | Unifocal | 1.5-2 |
Patient 6 | 3 focal lesions | 3-4, 1 and 1 |
Patient 7 | Unifocal | 4 |
Patient 8 | 3 focal lesions | 4, 1 and 1 |
Patient 9 | 3 focal lesions | 1, 1 and 1.5 |
Patient 10 | Unifocal | 2.5 |
Patient 11 | 2 focal lesions | 1 and 1.7 |
Patient 12 | 3 focal lesions | 1, 1 and 1 |
Patient 13 | Unifocal | 3 |
Patient 14 | 3 focal lesions | 3, 1.5 and 2 |
Patient 15 | 3 focal lesions | 1, 1 and 4 |
Patient 16 | 2 focal lesions | 3 and 1.5 |
Patient 17 | 2 focal lesions | 1.5 and 3 |
Patient 18 | 3 focal lesions | 2.5, 2.5 and 1.5 |
Patient 19 | 3 focal lesions | 1.5, 1 and 1 |
Patient 20 | Unifocal | 2 |
Patient 21 | Unifocal | 1.5 |
Patient 22 | 3 focal lesion | 3, 2.5 and 1 |
Patient 23 | Unifocal | 3 |
- Citation: Habashy DA, El Tayebi HM, Fawzy IO, Hosny KA, Esmat G, Abdelaziz AI. Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma. World J Hepatol 2016; 8(23): 976-984
- URL: https://www.wjgnet.com/1948-5182/full/v8/i23/976.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i23.976